A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study

OBJECTIVES: This study was conducted to evaluate the effect of low-dose chlormadinone acetate, an antiandrogen agent, on the persistence rate of active surveillance in patients with low-risk prostate cancer. METHODS: The study was a multicenter, placebo-controlled, double-blind, randomized controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Mikio, Kakehi, Yoshiyuki, Horie, Shigeo, Hirao, Yoshihiko, Akaza, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825478/
https://www.ncbi.nlm.nih.gov/pubmed/34698353
http://dx.doi.org/10.1093/jjco/hyab162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825478/
https://www.ncbi.nlm.nih.gov/pubmed/34698353
http://dx.doi.org/10.1093/jjco/hyab162

Ejemplares similares